HU176709B - Process for preparing new trisubstituted 1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine derivatives - Google Patents

Process for preparing new trisubstituted 1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine derivatives Download PDF

Info

Publication number
HU176709B
HU176709B HU77SI1605A HUSI001605A HU176709B HU 176709 B HU176709 B HU 176709B HU 77SI1605 A HU77SI1605 A HU 77SI1605A HU SI001605 A HUSI001605 A HU SI001605A HU 176709 B HU176709 B HU 176709B
Authority
HU
Hungary
Prior art keywords
tetrahydro
chloro
acid
hydrogen
formula
Prior art date
Application number
HU77SI1605A
Other languages
German (de)
English (en)
Hungarian (hu)
Inventor
Joseph Weinstock
Original Assignee
Smithkline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Corp filed Critical Smithkline Corp
Publication of HU176709B publication Critical patent/HU176709B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00Compounds having —CHO groups
    • C07C47/52Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/575Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D497/00Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU77SI1605A 1976-11-17 1977-11-17 Process for preparing new trisubstituted 1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine derivatives HU176709B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/742,965 US4160765A (en) 1976-11-17 1976-11-17 Method for 6-bromination of 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds

Publications (1)

Publication Number Publication Date
HU176709B true HU176709B (en) 1981-04-28

Family

ID=24986959

Family Applications (1)

Application Number Title Priority Date Filing Date
HU77SI1605A HU176709B (en) 1976-11-17 1977-11-17 Process for preparing new trisubstituted 1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine derivatives

Country Status (37)

Country Link
US (1) US4160765A (US20080293856A1-20081127-C00150.png)
JP (3) JPS5363335A (US20080293856A1-20081127-C00150.png)
AR (1) AR224495A1 (US20080293856A1-20081127-C00150.png)
AT (1) AT362379B (US20080293856A1-20081127-C00150.png)
AU (1) AU509754B2 (US20080293856A1-20081127-C00150.png)
BE (1) BE860774A (US20080293856A1-20081127-C00150.png)
BG (1) BG30019A3 (US20080293856A1-20081127-C00150.png)
CA (1) CA1092107A (US20080293856A1-20081127-C00150.png)
CH (1) CH635079A5 (US20080293856A1-20081127-C00150.png)
CS (1) CS219333B2 (US20080293856A1-20081127-C00150.png)
CY (1) CY1246A (US20080293856A1-20081127-C00150.png)
DD (1) DD133563A5 (US20080293856A1-20081127-C00150.png)
DE (1) DE2751258A1 (US20080293856A1-20081127-C00150.png)
DK (1) DK156057C (US20080293856A1-20081127-C00150.png)
ES (1) ES464044A1 (US20080293856A1-20081127-C00150.png)
FI (1) FI67374C (US20080293856A1-20081127-C00150.png)
FR (1) FR2371430A1 (US20080293856A1-20081127-C00150.png)
GB (1) GB1595502A (US20080293856A1-20081127-C00150.png)
HU (1) HU176709B (US20080293856A1-20081127-C00150.png)
IE (1) IE46087B1 (US20080293856A1-20081127-C00150.png)
IL (1) IL53377A (US20080293856A1-20081127-C00150.png)
IN (1) IN150172B (US20080293856A1-20081127-C00150.png)
IT (1) IT1126216B (US20080293856A1-20081127-C00150.png)
LU (1) LU78513A1 (US20080293856A1-20081127-C00150.png)
MX (1) MX4682E (US20080293856A1-20081127-C00150.png)
MY (1) MY8500382A (US20080293856A1-20081127-C00150.png)
NL (2) NL185563C (US20080293856A1-20081127-C00150.png)
NO (1) NO147029C (US20080293856A1-20081127-C00150.png)
PH (2) PH13611A (US20080293856A1-20081127-C00150.png)
PL (1) PL109672B1 (US20080293856A1-20081127-C00150.png)
PT (1) PT67260B (US20080293856A1-20081127-C00150.png)
RO (1) RO72905A (US20080293856A1-20081127-C00150.png)
SE (1) SE436646B (US20080293856A1-20081127-C00150.png)
SG (1) SG31784G (US20080293856A1-20081127-C00150.png)
SU (1) SU976847A3 (US20080293856A1-20081127-C00150.png)
YU (1) YU40490B (US20080293856A1-20081127-C00150.png)
ZA (1) ZA775910B (US20080293856A1-20081127-C00150.png)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197297A (en) * 1976-11-17 1980-04-08 Smithkline Corporation 6-Halo-7,8-dihydroxy-1-(hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepines
JPS5481290A (en) * 1977-11-17 1979-06-28 Smithkline Corp Benzazepin compound
US4171359A (en) * 1978-04-12 1979-10-16 Smithkline Corporation Benz-tetrasubstituted 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
ZA792043B (en) * 1978-05-08 1980-05-28 Scherico Ltd Esters of substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines,process for the preparation thereof and pharmaceutical compositions containing them
US4251525A (en) * 1979-05-25 1981-02-17 Smithkline Corporation 3-Allyl-7,8-dihydroxy-6-halo-1-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine derivatives
DE3065940D1 (en) * 1979-07-10 1984-01-26 Smithkline Beckman Corp Synergistic antihypertensive compositions
US4285938A (en) * 1979-10-11 1981-08-25 Smithkline Corporation 7,8-Dihydroxy-1-(sulfamylphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine derivatives
US4284556A (en) * 1980-01-31 1981-08-18 Smithkline Corporation 7,8-Amino, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4328153A (en) * 1980-07-17 1982-05-04 Smith Kline Corporation Dopaminergic benzazepines
ATE15762T1 (de) * 1981-12-08 1985-10-15 Smithkline Beckman Corp Pharmazeutische zusammensetzungen mit gehalt an 7,8-dihydroxy-1-(hydroxy-phenyl)-2,3,4,5tetrahydro-1h-3-benzazepin-derivaten und an einem beta-adrenergischen blocker.
US4705862A (en) * 1984-10-05 1987-11-10 Smithkline Beckman Corporation Chemical processes for 2-(2-halo-3,4-dimethoxybenzyl)-5-(4-methoxyphenyl)oxazolidines
US4782163A (en) * 1984-10-05 1988-11-01 Smithkline Beckman Corporation 2-(2-halo-3,4-dimethoxybenzyl)-5-(4-methoxyphenyl)-oxazolidines
US5068326A (en) * 1989-04-03 1991-11-26 Kung Hank F Dopamine receptor ligands and imaging agents
KR20010113006A (ko) * 2000-06-15 2001-12-24 주정호 항암제로서 유용한 n-치환된 벤즈아제피닐우레아 유도체및 그의 제조방법
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7585493B2 (en) 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
JP2007516149A (ja) 2003-05-21 2007-06-21 アレックザ ファーマシューティカルズ, インコーポレイテッド 基板温度の均一性を制御する方法、および、内蔵式加熱ユニットおよびそれを使用する薬剤供給ユニット
GB0412314D0 (en) * 2004-06-02 2004-07-07 Glaxo Group Ltd Compounds
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
AU2004322756B2 (en) 2004-08-12 2011-04-14 Alexza Pharmaceuticals, Inc. Aerosol drug delivery device incorporating percussively activated heat packages
CA2593667A1 (en) * 2005-01-24 2006-07-27 Sicor Inc. Process for the preparation of fenoldopam mesylate
US20080216828A1 (en) 2007-03-09 2008-09-11 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
CN104876869B (zh) * 2011-12-22 2017-06-30 四川科伦药物研究院有限公司 一种手性菲诺多泮的拆分方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393192A (en) * 1965-04-26 1968-07-16 Schering Corp Novel benzazepines
GB1118688A (en) * 1967-02-17 1968-07-03 Scherico Ltd Novel benzazepines and process for making same
CH498122A (de) * 1968-02-09 1970-10-31 Geigy Ag J R Verfahren zur Herstellung eines neuen Tetrahydroazepinderivates
CH555831A (de) * 1967-02-17 1974-11-15 Scherico Ltd Verfahren zur herstellung von neuen benzazepinen.
DE1695844C3 (de) * 1967-02-21 1980-01-17 Scherico Ltd., Luzern (Schweiz) l-Phenyl-23,43-tetrahydro-lH^benzazepin-Derivate und sie enthaltende pharmazeutische Zusammensetzungen
US3609138A (en) * 1967-12-22 1971-09-28 Ciba Geigy Corp 1-aryl-3-benzazepines
US4011319A (en) * 1975-07-02 1977-03-08 Smithkline Corporation Pharmaceutical compositions and methods involving benzazepine derivatives

Also Published As

Publication number Publication date
PT67260B (en) 1979-04-18
FI773448A (fi) 1978-05-18
NL930026I1 (nl) 1993-06-01
AR224495A1 (es) 1981-12-15
NL7712567A (nl) 1978-05-19
DE2751258C2 (US20080293856A1-20081127-C00150.png) 1990-01-04
YU40490B (en) 1986-02-28
SE436646B (sv) 1985-01-14
PH14740A (en) 1981-11-20
ZA775910B (en) 1978-05-30
US4160765A (en) 1979-07-10
JPS6125697B2 (US20080293856A1-20081127-C00150.png) 1986-06-17
IL53377A (en) 1982-09-30
BG30019A3 (en) 1981-03-16
IL53377A0 (en) 1978-01-31
SG31784G (en) 1985-03-08
GB1595502A (en) 1981-08-12
LU78513A1 (US20080293856A1-20081127-C00150.png) 1978-03-20
IN150172B (US20080293856A1-20081127-C00150.png) 1982-04-07
JPS62155218A (ja) 1987-07-10
AU509754B2 (en) 1980-05-22
FI67374B (fi) 1984-11-30
JPS6366808B2 (US20080293856A1-20081127-C00150.png) 1988-12-22
NO147029C (no) 1983-01-19
IE46087B1 (en) 1983-02-23
IT1126216B (it) 1986-05-14
CH635079A5 (de) 1983-03-15
NL930026I2 (nl) 1993-11-01
PL202177A1 (pl) 1978-09-25
NL185563B (nl) 1989-12-18
AT362379B (de) 1981-05-11
CS219333B2 (en) 1983-03-25
FI67374C (fi) 1985-03-11
SU976847A3 (ru) 1982-11-23
RO72905A (ro) 1981-11-04
DE2751258A1 (de) 1978-06-01
NL185563C (nl) 1990-05-16
DK500477A (da) 1978-05-18
ES464044A1 (es) 1978-08-01
BE860774A (fr) 1978-05-16
JPS5363335A (en) 1978-06-06
MY8500382A (en) 1985-12-31
DD133563A5 (de) 1979-01-10
SE7712944L (sv) 1978-05-18
NO147029B (no) 1982-10-11
CY1246A (en) 1984-08-31
JPS58113153A (ja) 1983-07-05
YU270777A (en) 1983-02-28
NO773901L (no) 1978-05-19
MX4682E (es) 1982-07-28
AU3062677A (en) 1979-05-24
DK156057B (da) 1989-06-19
JPS6225658B2 (US20080293856A1-20081127-C00150.png) 1987-06-04
IE46087L (en) 1978-05-17
PL109672B1 (en) 1980-06-30
ATA816377A (de) 1980-10-15
PH13611A (en) 1980-08-05
FR2371430B1 (US20080293856A1-20081127-C00150.png) 1980-06-27
DK156057C (da) 1989-11-13
CA1092107A (en) 1980-12-23
FR2371430A1 (fr) 1978-06-16
PT67260A (en) 1977-12-01

Similar Documents

Publication Publication Date Title
HU176709B (en) Process for preparing new trisubstituted 1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine derivatives
US4359464A (en) 3-Furylmethyl-6-halo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines and antihypertensive use thereof
US4255422A (en) 6-Halo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
NL192451C (nl) Werkwijze voor de bereiding van ftalanderivaten en werkwijze voor de bereiding van farmaceutische preparaten die een ftalanderivaat bevatten.
US4108989A (en) 2,3,4,5-tetrahydro-1h-3-benzazepine-7,8-diones
US4011319A (en) Pharmaceutical compositions and methods involving benzazepine derivatives
JPS6341912B2 (US20080293856A1-20081127-C00150.png)
US4104379A (en) Substituted 1-alkylthiophenyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds
CA1079639A (en) 3-benzazepine derivatives
EP0004794B1 (en) Substituted benzazepines, processes for preparing them and pharmaceutical compositions containing them
KR910003116B1 (ko) 치환된 1h-이미다졸
JPS62185075A (ja) インデノ〔1,7−cd〕アゼピン類
US4206210A (en) Alkylthio-7,8-dihdroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines having dopaminergic activity
JPS61106577A (ja) フロ−〔3,2−c〕ピリジン誘導体、その製造法およびそれを含有する医薬組成物
US4052506A (en) Pharmaceutical compositions and method of producing anti-parkinsonism activity
CA1090334A (en) Alkylthio-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro- 1h-3-benzazepines having dopaminergic activity
EP0002327A1 (en) Pharmacologically active 6-lower alkyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines, method of preparing them and intermediates
US4352754A (en) 3-Thienylmethyl-6-halo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4165372A (en) 6-Carboxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds and use as dopaminergic agents
US4172890A (en) 2,3,4,5-Tetrahydro-1H-3-benzazepine-7,8-diones
JPS62238271A (ja) 1−フエニル−3−ベンズアゼピン類
CH637383A5 (en) Trisubstituted 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines, and their salts
KR820001340B1 (ko) 치환된 1-티에닐 또는 푸릴-2, 3, 4, 5-테트라하이드로 1h-3-벤자제핀 화합물의 제법
AT359511B (de) Verfahren zur herstellung von neuen 1-(2'- thienyl)-und 1-(2'-furyl)-2,3,4,5-tetrahydro-1h -3-benzazepinen und von ihren salzen
DK157925B (da) 2,3,4,5-tetrahydro-1h-3-benzazepinderivater og farmaceutiske praeparater indeholdende disse

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HMM4 Cancellation of final prot. due to non-payment of fee